Telehealth GLP-1 programs generally run $200 to $700-plus per month as of April 2026, depending on the medication, subscription tier, and whether the fill is branded or compounded
Retatrutide, also known by its research name LY-3437943, is an investigational once-weekly injectable drug developed by Eli Lilly
It works with choline to help emulsify fats, breaking them down and preventing them from accumulating in places they shouldn't, like the liver and arteries
We now have randomized controlled trial data from 2024 and a prospective substudy from 2025 documenting measurable changes in both
In: Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd ed